Stueland Katherine bought WGS
March 6, 2026 · Form 4 insider transaction
Stueland Katherine bought 3,404 shares of GeneDx Holdings Corp. at $88.11 per share, a transaction worth $299.9K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,404
Price
$88.11
Total value
$299.9K
InsiderStueland Katherine
RoleOfficer, Director
CompanyGeneDx Holdings Corp. (WGS)
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateMarch 6, 2026
Filing dateMarch 9, 2026
Shares owned after42,087
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Pursuant to a Subscription Agreement executed on March 6, 2026 between GeneDx Holdings Corp. (the "Issuer") and the reporting person, the reporting person acquired 3,404 shares of the Issuer's Class A common stock directly from the Issuer in an exempt transaction pursuant to Rule 16b-3(d) at a purchase price of $88.11 per share, the closing price of the Issuer's Class A common stock on March 6, 2026.